


Another NameVerzenios,LuciAbe,阿贝西利
IndicationsIndicated for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative early-stage, late-stage, or metastatic breast cancer in adults.
Reg No.03 L 1324/25
Inspection No.759-25
WhatsApp: